Search the Newsreel

Valiant Laboratories Q1 Results: Net profit jumps 422% YoY to ₹9.48 cr

Labcorp Holdings Inc. (NYSE:LH) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Labcorp Holdings Inc. (NYSE:LH) has received a consensus "Moderate Buy" rating from twelve brokerages, with an average 12-month price target of $330.00. The company recently surpassed quarterly earnings expectations with $4.99 EPS and $3.73 billion in revenue, and declared a quarterly dividend of $0.72 …

Abbott Laboratories (NYSE:ABT) Receives Consensus Rating of "Moderate Buy" from Brokerages

Abbott Laboratories (NYSE:ABT) has received a consensus "Moderate Buy" rating from twenty-six brokerages, with an average 12-month price target of $118.17. The company recently exceeded quarterly expectations with adjusted EPS of $1.31 and revenue of $12.59 billion, and announced a quarterly dividend of $0.63 …

Dr. Reddy's Laboratories slides Wednesday, underperforms competitors

Dr. Reddy's Laboratories Ltd. shares fell 0.50% on Wednesday to 1,198.95 Indian rupees, underperforming the broader market as the BSE SENSEX Index dropped 0.24%. The company's stock closed 15.23% below its 52-week high achieved on June 29th.

Barclays Adjusts Price Target on IDEXX Laboratories to $710 From $800, Keeps Overweight Rating

Barclays has updated its price target for IDEXX Laboratories (IDXX), lowering it to $710 from the previous $800. Despite this adjustment, the firm has decided to maintain its Overweight rating on the stock. This indicates a continued positive outlook on the company's performance, even …

IDEXX launches in-clinic cardiac test for cats and dogs

IDEXX Laboratories Inc. has launched the Catalyst proBNP Test, an in-clinic diagnostic tool for heart disease in cats and dogs. This test measures the NT-proBNP biomarker, providing rapid quantitative results to veterinarians for screening, diagnosis, and monitoring of cardiac conditions. The test will be …

Abony Acquisition Corp. I (AACO) earns $2.4M interest while holding $232.9M in trust

Abony Acquisition Corp. I (AACO), a blank check company, reported a net income of $2.4 million for the six months ended June 30, 2026, primarily from $2.9 million in interest earned on its Trust Account investments. The company holds $232.9 million in its Trust …

JHS Svendgaard Laboratories consolidated net profit rises 2.83% in the June 2026 quarter

IDEXX Laboratories (IDXX) Unveils First Dual Species Cardiac Test For Dogs And Cats

If EPS Growth Is Important To You, Arvee Laboratories (India) (NSE:ARVEE) Presents An Opportunity

¿Puede Abbott Laboratories (ABT) Estar 8% Infravalorada Tras Mejorar Su Previsión Anual?

Bio-Rad (BIO) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Tuesday, Aug. 4, 2026 at 5 p.m. ET CALL PARTICIPANTS Head of Investor Relations - Ruben ArguetaChief Executive Officer - Norman SchwartzPresident and Chief Operating Officer - Jonathan DiVincenzoExecutive Vice President and Chief Financial Officer - Roop Lakkaraju …

Cabot CEO Sean Keohane sells $7.9m in stock

Cabot Corp CEO Sean Keohane sold common stock worth approximately $7.9 million on August 7, 2026, after exercising employee stock options. He acquired 91,923 shares at $62.24 each and then sold them at a weighted average price of $86.4053. Following these transactions, Keohane directly …

Abbott Laboratories (ABT) schedules NYSE sale of stock from vested awards

Abbott Laboratories (ABT) has filed a Form 144 indicating a planned sale of 5,850 common shares through UBS Financial Services on or after August 11, 2026, on the NYSE. The shares originate from vested restricted stock awards granted on February 27, 2026, totaling 1,960, …

Abony Acquisition Corp. I Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

Abony Acquisition Corp. I announced its financial results for the second quarter and six months ending June 30, 2026. For the second quarter, the company reported a net income of USD 1.84 million, while the net income for the six-month period reached USD 2.39 …

Insider Selling: Charles River Laboratories International (NYSE:CRL) Director Sells $7,901,575.00 in Stock

Charles River Laboratories International Director James Foster sold 28,733 shares of NYSE:CRL stock for approximately $7.9 million at an average price of $275, reducing his direct ownership by 47.63%. This transaction, conducted under a pre-arranged Rule 10b5-1 trading plan, comes amidst generally positive analyst …

Abony Acquisition Corp. I Q2 2026: Net income $1.84M, EPS $0.06— 10-Q Summary

Abony Acquisition Corp. I reported a net income of $1.84 million and diluted EPS of $0.06 for Q2 2026, primarily from interest earned on its trust account investments. The company has not yet begun operating activities and is actively seeking a business combination, with …

Silicon Laboratories (SLAB) Beats Q2 Earnings Estimates

Silicon Laboratories (SLAB) came out with quarterly earnings of $0.71 per share, beating the Zacks Consensus Estimate of $0.67 per share. This compares to earnings of $0.11 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an …

IDEXX Laboratories Inc. stock underperforms Tuesday when compared to competitors

IDEXX Laboratories Inc. (IDXX) stock fell 1.53% on Tuesday, closing at $586.64, despite a general downturn in the stock market. The S&P 500 Index and Dow Jones Industrial Average also saw declines of 0.32% and 0.34%, respectively. The company's stock is now 23.81% below …

Grove Collaborative Faces NYSE Noncompliance, Potential Delisting Risk

Charles River Laboratories (CRL) EVP LaPlume reports bona fide gift of 257 shares

Joseph W. LaPlume, EVP, Corp Strategy & Develop at Charles River Laboratories International, Inc. (CRL), reported a bona fide gift of 257 shares of common stock on August 10, 2026. This transaction was a disposition at a reported per-share price of $0.00, leaving LaPlume …

Charles River (CRL) director James C. Foster exercises options and sells 28,733 shares

Charles River Laboratories International director James C. Foster exercised stock options for 28,733 shares at $179.66 per share and immediately sold them at $275.00 per share on August 10, 2026, pursuant to a Rule 10b5-1 Trading Plan. This transaction resulted in an approximate pre-tax …

Silicon Laboratories (SLAB) Releases Q2 2026 Earnings: Revenue Up 18.3% but Losses Persist

Grove Collaborative receives NYSE non-compliance notice By Investing.com

Grove Collaborative Holdings Inc. (NYSE:GROV) has received a notice from the New York Stock Exchange for non-compliance with listing standards. The company failed to meet the requirement of an average global market capitalization of at least $50 million and stockholders' equity of at least …

Earnings Flash (SLAB) Silicon Laboratories Inc. Posts Q2 Adjusted EPS $0.71 per Share, vs. FactSet Est of $0.69

Earnings Flash (SLAB) Silicon Laboratories Inc. Reports Q2 Revenue $228.2M, vs. FactSet Est of $228.0M

Silicon Laboratories Inc. (SLAB) reported its Q2 revenue at $228.2 million, surpassing the FactSet estimate of $228.0 million. This financial update indicates a slight beat on revenue expectations for the second quarter. The company also reported Q2 adjusted EPS of $0.71 per share, exceeding …

Silicon Labs (NASDAQ: SLAB) grows Q2 sales as $231-per-share TI merger advances

Silicon Laboratories Inc. reported increased Q2 2026 sales to $228.2 million, up from $192.8 million the previous year, driven by both Industrial & Commercial and Home & Life products, with gross margin improving to 61.6%. Despite revenue growth, the company incurred a net loss …

Silicon Laboratories (NASDAQ:SLAB) Posts Earnings Results, Beats Expectations By $0.02 EPS

Silicon Laboratories (NASDAQ:SLAB) announced its quarterly earnings, surpassing analyst expectations with an EPS of $0.71 against a consensus of $0.69, and revenue of $228.19 million. The stock increased to $218.94, nearing its 52-week high, bringing its market capitalization to approximately $7.22 billion. Despite the …

Silicon Labs Reports Second Quarter 2026 Results

Silicon Labs reported strong financial results for the second quarter of 2026, with revenue reaching $228 million, an 18% increase year-over-year. The company saw significant growth in its Industrial & Commercial and Medical segments, along with improved profitability and a non-GAAP diluted earnings per …

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. SEC Filing (Aug 11, 2026)

This SEC filing (Form 144) for Charles River Laboratories International, Inc. (CRL) details a proposed sale of 6,500 shares of common stock, valued at $1,819,350.00, acquired through the exercise of stock options on August 11, 2026. The transaction was handled by UBS Financial Services, …

Grove Receives NYSE Continued Listing Standards Notice

Grove Collaborative Holdings, Inc. (NYSE: GROV) has received a notice from the NYSE regarding non-compliance with continued listing standards, specifically concerning its average global market capitalization and stockholders' equity. The company must submit a business plan within 45 days to demonstrate how it expects …

BTU Deadline: BTU Investors with Losses in Excess of $100K Have Opportunity to Lead Peabody Energy Corporation Securities Fraud Lawsuit

Rosen Law Firm is reminding investors of Peabody Energy Corporation (NYSE: BTU) who suffered losses exceeding $100,000 to consider joining a securities fraud class action lawsuit. The deadline to serve as lead plaintiff is August 24, 2026. The lawsuit alleges that Peabody Energy made …

Mesa Labs Posts Margin Surge, Pays Down $8.7 Million in Debt as New CEO Tackles Delivery Delays

Mesa Laboratories reported a 1% increase in Q1 revenue to $60.1 million, with adjusted operating income surging nearly 20% and gross margin expanding to 64.9% due to cost controls. The company generated $14.7 million in operating cash flow and repaid $8.7 million in debt, …

Silicon Laboratories (SLAB) Launches A New Bluetooth SoC, Is The IoT Upside Priced In?

Silicon Laboratories (SLAB) recently launched its BG2B Series 2 Bluetooth Low Energy SoC, a new ultra-low power wireless chip for battery-powered IoT devices. Despite a significant 65.57% year-to-date share price increase, the debate is whether the current price fully reflects the IoT upside, with …

Abbott Partners With Google Health For AI-Powered Glucose Monitoring

Abbott has partnered with Google Health to integrate its Lingo continuous glucose monitor (CGM) data into the Google Health app, offering AI-driven recommendations for non-diabetic users. This collaboration aims to help users make better lifestyle choices and will involve a large-scale metabolic health study. …

Mesa Laboratories (NASDAQ:MLAB) Sees Large Volume Increase - What's Next?